SCHEMBL29611545

SCHEMBL29611545

O=C1CCC(N2C(=O)c3ccc(C4CCN(Cc5ccccc5)C4)c4cccc2c34)C(=O)N1

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
IKZF2 Q9UKS7 5/20 0.55
DDB1 Q16531 10/20 0.47
CRBN Q96SW2 10/20 0.47
IKZF3 Q9UKT9 4/20 0.45
ALDH1A1 P00352 1/20 0.45
CHRM2 P08172 1/20 0.45
OPRM1 P35372 1/20 0.45
CYP1A2 P05177 1/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
BCL2L11 O43521 1/20 0.44
BCL2 P10415 1/20 0.44
MCL1 Q07820 1/20 0.44
IKZF1 Q13422 6/20 0.44
TNF P01375 1/20 0.41
IL1B P01584 1/20 0.41
TBXA2R P21731 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24315890 1.00 IKZF2 (0.55) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL24315904 0.95 IKZF2 (0.60) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL29610888 0.95 IKZF2 (0.60) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL24315963 0.94 IKZF2 (0.51) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL24315961 0.87 IKZF2 (0.47) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL29611195 0.87 IKZF2 (0.47) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL24329414 0.86 CRBN (0.48) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL24315773 0.86 IKZF2 (0.52) IKZF2DDB1CRBNIKZF3ALDH1A1
SCHEMBL26657535 0.86 IKZF2 (0.40) IKZF2ALDH1A1OPRM1
Hydrochloric Acid SCHEMBL29583284 0.85 CRBN (0.48) IKZF2DDB1CRBNIKZF3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4228639-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 Therapeutics, Inc. (US) 2023-08-23 EP disclosed
WO-2022081925-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed